logo-alt.png
Global Blood Cell Separation Market – Rising incidence of cancer is encouraging further research in the field, Advances in computer techniques etc. driving market growth - by PMI
January 12, 2021 23:05 ET | PMI
Covina, CA, Jan. 12, 2021 (GLOBE NEWSWIRE) -- The market is driven by the increasing use of cell separation in cancer research. In addition, the rising focus on personalized medicine is anticipated...
logo-alt.png
Global Non-alcoholic Steatohepatitis Biomarkers Market Accounted for US$ 556.6 Billion in 2019 and is Estimated to be US$ 8177.9 Billion by 2029 and is Anticipated to Register a CAGR of 31.3%
August 18, 2020 10:05 ET | PMI
Covina, CA, Aug. 18, 2020 (GLOBE NEWSWIRE) -- The report "Global Non-alcoholic Steatohepatitis Biomarkers Market, By Type (Serum Biomarkers, Hepatic Fibrosis Biomarkers, Apoptosis Biomarkers,...
logo-alt.png
Global Wireless ECG Devices Market is estimated to be US$ 3.1 Billion by 2029 with a CAGR of 12.1% during the forecast period - PMI
July 09, 2020 10:40 ET | PMI
Covina, CA, July 09, 2020 (GLOBE NEWSWIRE) -- The global wireless ECG devices market accounted for US$ 1.0 billion in 2019 and is estimated to be US$ 3.1 billion by 2029 and is anticipated to...
logo-alt.png
Global Internet-of-Medical-Things (IoMT) Market Paved Way for Extensive Healthcare Modernization - PMI
July 02, 2020 10:05 ET | PMI
Covina, CA, July 02, 2020 (GLOBE NEWSWIRE) -- The global internet-of-medical-things (IoMT) market accounted for US$ 24.4 billion in 2019 and is estimated to be US$ 285.5 billion by 2029 and is...
logo-alt.png
Global Molecular Imaging Market is estimated to be US$ 13.7 Billion by 2029 with a CAGR of 7.3% during the Forecast Period - PMI
June 12, 2020 12:05 ET | PMI
Covina, CA, June 12, 2020 (GLOBE NEWSWIRE) -- The global molecular imaging market accounted for US$ 6.8 billion in 2019 and is estimated to be US$ 13.7 billion by 2029 and is anticipated to register...
KinetiCor Expands Patent Portfolio in China, Europe, and The United States to 33 Patents Issued 
March 16, 2020 11:00 ET | KinetiCor
 Leading Provider of Motion Detection and Correction Technology for MR Scans Opens New Frontiers in Biomedical Imaging Working with OEM Partners Worldwide SAN DIEGO, March 16, 2020 (GLOBE NEWSWIRE)...
KinetiCor Names Twenty-One Year Veteran of GE and GE Healthcare, Michael Jones, as Chairman of its Business Advisory Board
February 18, 2020 08:00 ET | KinetiCor
SAN DIEGO, Feb. 18, 2020 (GLOBE NEWSWIRE) -- KinetiCor, Inc., today’s only FDA 510(k) cleared optical motion detection solution1 for advanced Magnetic Resonance Imaging (MRI) scanners, is pleased to...
Jubilant Pharma.jpg
Jubilant Receives Favorable Rulings from the U.S. Patent Office Invalidating Bracco Rubidium-Infusion-System Patents
February 17, 2020 08:00 ET | Jubilant Pharma
YARDLEY, Pa., Feb. 17, 2020 (GLOBE NEWSWIRE) -- On February 7, 2020, Jubilant DraxImage Inc., and certain of its affiliates (“Jubilant”) were informed by the U.S. Patent Office that it agreed with...
KinetiCor Names Twenty-One Year Veteran of GE and GE Healthcare, Michael Jones, as Chairman of its Business Advisory Board
February 17, 2020 02:00 ET | KinetiCor
SAN DIEGO, Feb. 17, 2020 (GLOBE NEWSWIRE) -- KinetiCor, Inc., today’s only FDA 510(k) cleared optical motion detection solution1 for advanced Magnetic Resonance Imaging (MRI) scanners, is pleased to...
Jubilant Pharma.jpg
Jubilant Radiopharma Receives Approval from Health Canada for Drax Exametazime®
January 27, 2020 16:05 ET | Jubilant Pharma
YARDLEY, Pa., Jan. 27, 2020 (GLOBE NEWSWIRE) -- Jubilant Radiopharma, the Radiopharmaceutical Division of Jubilant Pharma Ltd, announced today that the company received approval from Health Canada...